Purple Biotech reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Purple Biotech using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-15 | $-0.39 | $-0.06 | -550.0 % |
Q2 | 2024-08-16 | $-1.80 | $-3.60 | 50.0 % |
Q1 | 2024-05-21 | $-2.80 | $-3.80 | 26.3 % |
Q4 | 2024-03-05 | $-3.80 | $-3.80 | 0.00 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Purple Biotech (PPBT) is scheduled to report earnings on March 4, 2025. The last reported earnings were for reported on November 15, 2024 for Q3.
The Actual EPS was $-0.39, which missed the estimate of $-0.06.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.